Effexor vs. Pristiq
See how Effexor and Pristiq compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Effexor and Pristiq are both SNRIs that raise serotonin and norepinephrine levels, and Pristiq is actually the active metabolite your body converts Effexor into.
Effexor is FDA-approved for depression, generalized anxiety, social anxiety, and panic disorder, while Pristiq is approved only for major depressive disorder.
Effexor requires a step-up dosing schedule over several weeks, but Pristiq uses one flat 50 mg dose from the start with no titration needed.
Effexor vs. Pristiq Drug Summary
Effexor
Effexor (venlafaxine) is a serotonin-norepinephrine reuptake inhibitor (SNRI) approved for major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder. It comes as an extended-release capsule taken once daily, with the dose increased gradually from 37.5 mg up to a maximum of 225 mg.
Pristiq
Pristiq (desvenlafaxine) is an SNRI that is actually the active metabolite Effexor breaks down into in the body, approved specifically for major depressive disorder in adults. It comes as an extended-release tablet taken once daily at a single 50 mg dose, with no titration required.
Effexor vs. Pristiq Side Effects
Effexor
Pristiq
Effexor vs. Pristiq Dosage
Effexor
Pristiq
| STAGE | DOSE | WHEN |
| Starting dose | 37.5 mg once daily | Days 1-7 |
| Maximum dose | 225 mg once daily | If needed |
| Dose changes | 3 increases | Every 7 days |
| STAGE | DOSE | WHEN |
| Starting dose | 50 mg once daily | At the start |
| Maximum dose | 50 mg once daily | Same as starting |
| Dose changes | None | Fixed dose |
Effexor
| STAGE | DOSE | WHEN |
| Starting dose | 37.5 mg once daily | Days 1-7 |
| Maximum dose | 225 mg once daily | If needed |
| Dose changes | 3 increases | Every 7 days |
Pristiq
| STAGE | DOSE | WHEN |
| Starting dose | 50 mg once daily | At the start |
| Maximum dose | 50 mg once daily | Same as starting |
| Dose changes | None | Fixed dose |
Effexor vs. Pristiq Indications
Effexor
Effexor is approved for major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder with or without agoraphobia. Doctors also prescribe it off-label for chronic nerve pain and hot flashes tied to menopause.
Major depressive disorder (MDD)
Generalized anxiety disorder (GAD)
Social anxiety disorder (SAD)
Panic disorder, with or without agoraphobia
Pristiq
Pristiq is FDA-approved only for treating major depressive disorder in adults. It does not carry FDA approval for anxiety disorders, panic disorder, or any specific off-label uses.
Major depressive disorder (MDD) in adults
Not approved for generalized anxiety, social anxiety, or panic disorder
Not approved for pediatric patients
No FDA-recognized off-label indications on the label
Effexor vs. Pristiq Pros and Cons
Effexor
Effexor covers a wider range of anxiety and mood disorders than Pristiq, reflecting its longer history on the market. As an older SNRI, it is available as a low-cost generic in both extended-release and immediate-release forms.
Pros
Approved for four conditions: MDD, GAD, SAD, and panic disorder
Decades of real-world prescribing history since 1997
Available as a low-cost generic in capsule and tablet forms
Also used off-label for chronic nerve pain and menopausal hot flashes
Cons
Needs a gradual dose increase over several weeks to reach an effective level
Immediate-release version requires multiple doses per day
Higher risk of sustained blood pressure increases at higher doses
Metabolized by CYP2D6, so levels can vary with genetics and drug interactions
Pristiq
Pristiq's single fixed dose can simplify treatment since no titration schedule is needed to reach an effective level. As the active form of venlafaxine, it skips a liver conversion step that affects patients differently.
Pros
Simple flat 50 mg dose with no titration schedule
Not processed through CYP2D6, so fewer metabolism-related interactions
Already the active form of venlafaxine, so no conversion step is needed
Fewer dose options to manage since only one dose is used
Cons
Approved only for depression, not for anxiety or panic disorders
No higher dose option if response is inadequate, since more offers no added benefit
Shorter track record on the market, approved in 2008 versus 1997
Still carries the same boxed warning and serotonin syndrome risk as Effexor
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.